- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 11/00 - Depsipeptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 11/00
Total number of patents in this class: 117
10-year publication summary
6
|
6
|
7
|
10
|
11
|
10
|
6
|
3
|
9
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Onkure, Inc. | 26 |
5 |
Sanofi | 4040 |
4 |
Novartis AG | 10856 |
3 |
The Regents of the University of California | 19887 |
3 |
Massachusetts Institute of Technology | 10041 |
3 |
Board of Regents, The University of Texas System | 5782 |
3 |
President and Fellows of Harvard College | 5972 |
3 |
Agency for Science, Technology and Research | 3610 |
2 |
University of Florida Research Foundation, Inc. | 4016 |
2 |
The Broad Institute, Inc. | 1800 |
2 |
Chugai Seiyaku Kabushiki Kaisha | 1351 |
2 |
Karus Therapeutics Limited | 27 |
2 |
Nanyang Technological University | 1999 |
2 |
Osaka Prefecture University Public Corporation | 241 |
2 |
The Regents of the University of Colorado, a body corporate | 2638 |
2 |
Shenzhen Institutes of Advanced Technology | 1488 |
2 |
Stella Pharma Corporation | 37 |
2 |
University of Vermont and State Agricultural College | 383 |
2 |
The USA, as represented by the Secretary, Dept. of Health and Human Services | 84 |
2 |
Sichuan Gooddoctor Panxi Pharmaceutical Co.,Ltd. | 25 |
2 |
Other owners | 67 |